Search for: "T.H v. Novartis Pharmaceuticals"
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
17 Jan 2018, 1:37 pm
S.C., Dec. 21, 2017, T.H. v. [read post]
17 Jan 2018, 1:29 pm
S.C., Dec. 21, 2017, T.H. v. [read post]
14 Jan 2018, 4:00 am
S.C., Dec. 21, 2017, T.H. v. [read post]
17 Jan 2018, 1:16 pm
S.C., Dec. 21, 2017, T.H. v. [read post]
14 Jan 2018, 6:34 am
S.C., Dec. 21, 2017, T.H. v. [read post]
17 Jan 2018, 1:25 pm
S.C., Dec. 21, 2017, T.H. v. [read post]
13 Jan 2018, 8:00 pm
S.C., Dec. 21, 2017, T.H. v. [read post]
11 May 2018, 8:59 am
The case was T.H. v. [read post]
12 Feb 2018, 3:02 am
Henderson] California Supreme Court rules research drugmakers legally responsible “for harm caused by defective warnings in labels on generic versions of their products” [T.H. v. [read post]
12 Dec 2017, 3:01 am
[Steven Boranian/Drug & Device Law, PLF on T.H. v. [read post]
26 Jun 2016, 3:31 am
All this makes it interesting that the California Supreme Court will be taking on the issue of “innovator liability,” also known as brand manufacturer liability for generics in the case of T.H. v. [read post]
18 Mar 2016, 2:04 pm
Novartis Pharmaceuticals Corp., No. [read post]
28 Jun 2016, 9:02 am
In T.H. v. [read post]
